S-Nitrosylation-mediated coupling of DJ-1 with PTEN induces PI3K/AKT/mTOR pathway-dependent keloid formation

Abstract

Background: Keloids are aberrant dermal wound healing characterized by invasive growth, extracellular matrix deposition, cytokine overexpression and easy recurrence. Many factors have been implicated as pathological causes of keloids, particularly hyperactive inflammation, tension alignment and genetic predisposition. S-Nitrosylation (SNO), a unique form of protein modification, is associated with the local inflammatory response but its function in excessive fibrosis and keloid formation remains unknown. We aimed to discover the association between protein SNO and keloid formation. Methods: Normal and keloid fibroblasts were isolated from collected normal skin and keloid tissues. The obtained fibroblasts were cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. The effects of DJ-1 on cell proliferation, apoptosis, migration and invasion, and on the expression of proteins were assayed. TurboID-based proximity labelling and liquid chromatography-mass spectrometry were conducted to explore the potential targets of DJ-1. Biotin-switch assays and transnitrosylation reactions were used to detect protein SNO. Quantitative data were compared by two-tailed Student’s t test. Results: We found that DJ-1 served as an essential positive modulator to facilitate keloid cell proliferation, migration and invasion. A higher S-nitrosylated DJ-1 (SNO-DJ-1) level was observed in keloids, and the effect of DJ-1 on keloids was dependent on SNO of the Cys106 residue of the DJ-1 protein. SNO-DJ-1 was found to increase the level of phosphatase and tensin homolog (PTEN) S-nitrosylated at its Cys136 residue via transnitrosylation in keloids, thus diminishing the phosphatase activity of PTEN and activating the PI3K/AKT/mTOR pathway. Furthermore, Cys106-mutant DJ-1 is refractory to SNO and abrogates DJ-1-PTEN coupling and the SNO of the PTEN protein, thus repressing the PI3K/AKT/mTOR pathway and alleviating keloid formation. Importantly, the biological effect of DJ-1 in keloids is dependent on the SNO-DJ-1/SNO-PTEN/PI3K/AKT/mTOR axis. Conclusions: For the first time, this study demonstrated the effect of transnitrosylation from DJ-1 to PTEN on promoting keloid formation via the PI3K/AKT/mTOR signaling pathway, suggesting that SNO of DJ-1 may be a novel therapeutic target for keloid treatment.

Keywords

DJ-1 / PTEN / Protein S-nitrosylation / Transnitrosylation / Keloid / S-Nitrosylation

References

[1] Jagdeo J, Kerby E, Glass DA, 2nd. Keloids. JAMA Dermatol. 2021; 157: 744.

[2] Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020; 8: 360.

[3] Hawash AA, Ingrasci G, Nouri K, Yosipovitch G. Pruritus in keloid scars: mechanisms and treatments. Acta Derm Venereol. 2021; 101: adv00582.

[4] Li Y, Li M, Qu C, Li Y, Tang Z, Zhou Z, et al. The polygenic map of keloid fibroblasts reveals fibrosis-associated gene alterations in inflammation and immune responses. Front Immunol. 2021; 12: 810290.

[5] Grabowski G, Pacana MJ, Chen E. Keloid and hypertrophic scar formation, prevention, and management: standard review of abnormal scarring in orthopaedic surgery. J Am Acad Orthop Surg. 2020; 28: e408-14.

[6] Gusarov I, Nudler E. Protein S-Nitrosylation: enzymatically controlled, but intrinsically unstable, Post-translational modification. Mol Cell. 2018; 69: 351-3.

[7] Fernando V, Zheng X, Walia Y, Sharma V, Letson J, Furuta S. S-Nitrosylation: An emerging paradigm of redox Signaling. Antioxidants (Basel). 2019; 8: 404.

[8] Zhao Q, Ma J, Xie F, Wang Y, Zhang Y, Li H, et al. Recent advances in predicting protein S-Nitrosylation sites. Biomed Res Int. 2021; 2021: 5542224.

[9] Sharma V, Fernando V, Letson J, Walia Y, Zheng X, Fackelman D, et al. S-Nitrosylation in tumor microenvironment. Int J Mol Sci. 2021; 22: 4600. https://doi.org/10.3390/ijms22094600.

[10] Zhou HL, Premont RT, Stamler JS. The manifold roles of protein S-nitrosylation in the life of insulin. Nat Rev Endocrinol. 2022; 18: 111-28.

[11] Nakamura T, Oh CK, Zhang X, Tannenbaum SR, Lipton SA. Protein Transnitrosylation Signaling networks contribute to Inflammaging and neurodegenerative disorders. Antioxid Redox Signal. 2021; 35: 531-50.

[12] Dasgupta S, Gomez JJ, Singh I, Khan M. S-Nitrosylation in regulation of inflammation and cell damage. Curr Drug Targets. 2018; 19: 1831-8.

[13] Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Nitric oxide therapy for diabetic wound healing. Adv Healthc Mater. 2019; 8: e1801210.

[14] Neves M, Graos M, Anjo SI, Manadas B. Modulation of signaling pathways by DJ-1: An updated overview. Redox Biol. 2022; 51: 102283.

[15] Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997; 231: 509-13.

[16] Huang M, Chen S. DJ-1 in neurodegenerative diseases: pathogenesis and clinical application. Prog Neurobiol. 2021; 204: 102114.

[17] Xu M, Wu H, Li M, Wen Y, Yu C, Xia L, et al. DJ-1 deficiency protects hepatic steatosis by enhancing fatty acid oxidation in mice. Int J Biol Sci. 2018; 14: 1892-900.

[18] De Lazzari F, Prag HA, Gruszczyk AV, Whitworth AJ, Bisaglia M. DJ-1: a promising therapeutic candidate for ischemia-reperfusion injury. Redox Biol. 2021; 41: 101884.

[19] Lev N, Barhum Y, Lotan I, Steiner I, Offen D. DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS. PLoS One. 2015; 10: e0117190.

[20] Kim HS, Nam ST, Mun SH, Lee SK, Kim HW, Park YH, et al. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation. Nat Commun. 2017; 8: 1519.

[21] Dong Y, Lv D, Zhao Z, Xu Z, Hu Z, Tang B. Lycorine inhibits hypertrophic scar formation by inducing ROS-mediated apoptosis. Front Bioeng Biotechnol. 2022; 10: 892015.

[22] Lv D, Ding S, Zhong L, Tu J, Li H, Yao H, et al. M(6)a demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression. Oncogene. 2022; 41: 1727-41.

[23] Ding S, Wang X, Lv D, Tao Y, Liu S, Chen C, et al. EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma. Cancer Lett. 2022; 527: 49-65.

[24] Hao G, Derakhshan B, Shi L, Campagne F, Gross SS. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci U S A. 2006; 103: 1012-7.

[25] Kwak YD, Ma T, Diao S, Zhang X, Chen Y, Hsu J, et al. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol Neurodegener. 2010; 5: 49.

[26] Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003; 299: 256-9.

[27] Chen G, An N, Ye W, Huang S, Chen Y, Hu Z, et al. bFGF alleviates diabetes-associated endothelial impairment by down-regulating inflammation via S-nitrosylation pathway. Redox Biol. 2021; 41: 101904.

[28] Chao ML, Luo S, Zhang C, Zhou X, Zhou M, Wang J, et al. S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces hippo/YAP-dependent diabetes-accelerated atherosclerosis. Nat Commun. 2021; 12: 4452.

[29] Branon TC, Bosch JA, Sanchez AD, Udeshi ND, Svinkina T, Carr SA, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018; 36: 880-7.

[30] Cho KF, Branon TC, Udeshi ND, Myers SA, Carr SA, Ting AY. Proximity labeling in mammalian cells with TurboID and split-TurboID. Nat Protoc. 2020; 15: 3971-99.

[31] Hsieh SC, Lai CS, Chang CH, Yen JH, Huang SW, Feng CH, et al. Nitric oxide: is it the culprit for the continued expansion of keloids? Eur J Pharmacol. 2019; 854: 282-8.

[32] Hsu YC, Wang LF, Chien YW, Lee WR. Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide. J Dermatol Sci. 2007; 45: 37-44.

[33] Hsu YC, Hsiao M, Wang LF, Chien YW, Lee WR. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide. 2006; 14: 327-34.

[34] Kim KR, Cho EJ, Eom JW, Oh SS, Nakamura T, Oh CK, et al. S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders. Cell Death Differ. 2022; 29: 2137-50.

[35] Zhao Q, Zheng K, Ma C, Li J, Zhuo L, Huang W, et al. PTPS facilitates compartmentalized LTBP1 S-Nitrosylation and promotes tumor growth under hypoxia. Mol Cell. 2020; 77: 95-107.e5.

[36] Zhang L, Wang J, Wang J, Yang B, He Q, Weng Q. Role of DJ-1 in immune and inflammatory diseases. Front Immunol. 2020; 11: 994.

[37] Post KL, Belmadani M, Ganguly P, Meili F, Dingwall R, McDiarmid TA, et al. Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction. Nat Commun. 2020; 11: 2073.

[38] Yehia L, Keel E, Eng C. The clinical Spectrum of PTEN mutations. Annu Rev Med. 2020; 71: 103-16.

[39] Parapuram SK, Shi-wen X, Elliott C, Welch ID, Jones H, Baron M, et al. Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. J Invest Dermatol. 2011; 131: 1996-2003.

[40] Guo L, Chen L, Bi S, Chai L, Wang Z, Cao C, et al. PTEN inhibits proliferation and functions of hypertrophic scar fibroblasts. Mol Cell Biochem. 2012; 361: 161-8.

[41] Yu C, Xiong C, Tang J, Hou X, Liu N, Bayliss G, et al. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFbeta and notch signaling and preserving PTEN expression. Theranostics. 2021; 11: 2706-21.

[42] Parapuram SK, Thompson K, Tsang M, Hutchenreuther J, Bekking C, Liu S, et al. Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism. Matrix Biol. 2015; 43: 35-41.

[43] Nunnery SE, Mayer IA. Targeting the PI3K/AKT/mTOR pathway in hormone-positive breast cancer. Drugs. 2020; 80: 1685-97.

[44] Xie X, Man X, Zhu Z, Yuan D, Huang S. Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway. Obesity (Silver Spring). 2016; 24: 389-97.

[45] Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X, et al. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy. 2021; 17: 980-1000.

[46] Bathina S, Gundala NKV, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, et al. Resolvin D1 ameliorates nicotinamide-streptozotocin-induced type 2 diabetes mellitus by its anti-inflammatory action and modulating PI3K/Akt/mTOR pathway in the brain. Arch Med Res. 2020; 51: 492-503.

[47] Xin Y, Min P, Xu H, Zhang Z, Zhang Y, Zhang Y. CD26 upregulates proliferation and invasion in keloid fibroblasts through an IGF-1-induced PI3K/AKT/mTOR pathway. Burns Trauma. 2020; 8: tkaa025.

[48] Wang Q, Wang P, Qin Z, Yang X, Pan B, Nie F, et al. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia. et al.